Abera Bioscience AB (NGM:ABERA)
Sweden
· Delayed Price · Currency is SEK 6.00
-0.10 (-1.64%)
At close: Mar 9, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 125.04 million as of March 9, 2026. Its market cap has increased by 89.42% in one year.
Market Cap
125.04M
Enterprise Value
101.55M
Revenue
11.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.00
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 125.04M, an increase of 8.18%. That is a compound annual growth rate of 1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 122.99M | -1.95% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solution International Nordics AB | 127.18M |
| Eurobattery Minerals AB | 121.93M |
| Valuno Group AB | 128.89M |
| Amido AB | 117.55M |
| Nowonomics AB | 137.07M |
| Aquaticus Real Estate AB | 154.00M |
| Spotlight Group AB | 99.41M |
| EmbeddedArt Group AB | 158.67M |